Non-cytotoxic activity of B. jararacussu venom - Ruiz Rivero, José Vitelio
33,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
17 °P sammeln
  • Broschiertes Buch

Ophidian venoms are biological resources of important pharmacological value. In addition to the small number of antiviral drugs, numerous pathogens develop mechanisms to escape the action of drugs, resulting in increasing rates of resistance. Biomolecules contained in ophidian venoms have been shown to have high therapeutic value and could be used as antimicrobial agents. The aim of this work is to evaluate the non-cytotoxic activity of crude venom isolated from Bothrops jararacussu in peripheral blood mononuclear cells. In this study, mononuclear cells from healthy donors were separated.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Ophidian venoms are biological resources of important pharmacological value. In addition to the small number of antiviral drugs, numerous pathogens develop mechanisms to escape the action of drugs, resulting in increasing rates of resistance. Biomolecules contained in ophidian venoms have been shown to have high therapeutic value and could be used as antimicrobial agents. The aim of this work is to evaluate the non-cytotoxic activity of crude venom isolated from Bothrops jararacussu in peripheral blood mononuclear cells. In this study, mononuclear cells from healthy donors were separated. After activating the cells with phytohemagglutinin and interleukin-2, different concentrations of the venom were added to assess its non-cytotoxic activity. This study paves the way for new research aimed at identifying the antimicrobial activities of crude venoms and their fractions.
Autorenporträt
Graduated in Medicine from the Instituto Superior de Ciencias Médicas de Santiago de Cuba (2004). Master's degree in Environmental Sciences and Health from the Pontifical Catholic University of Goiás (2010). CNPq scholarship holder (2008-2009). Residency in Internal Medicine (2012-2014) and Cardiology (2014-2016). Developed health projects with indigenous Guatemalans.